And subsequent antitumor t_cell response in prostate cancer

HIGHLIGHTS

• who: UBC and colleagues from the DepartmentHuazhong University, Wuhan, China have published the research: and subsequent antitumor T_cell response in prostate cancer, in the Journal: (JOURNAL)
• what: The authors report that PCa growth in mice with macrophage-specific is substantially suppressed compared with that in wild-type littermates an effect partially ascribed to the augmented CD8+ T cell response. To investigate the clinical relevance of SUMOylation in PCa, the authors focused on UBC9, the most critical SUMO E2 conjugating enzyme, and queried a series of expression and survival data sets of PCa patients. In this . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.